Evidence map›Paper›PMID 40330930›Full record

ArticleAME case reports2025

Trauma-induced recurrent of scalp dermatofibrosarcoma protuberans: a case report with a 6-year follow-up and literature review.

Qian Ouyang, Yuxiang Zhou, Yongkai Huang

Abstract readCase Reports
In one paragraph

Article in AME case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Qian OuyangDepartment of Neurosurgery, Zhuzhou Hospital, Central South University Xiangya School of Medicine, Zhuzhou, China.ORCID https://orcid.org/0000-0002-9863-7020
Yuxiang ZhouDepartment of Neurosurgery, Zhuzhou Hospital, Central South University Xiangya School of Medicine, Zhuzhou, China.ORCID https://orcid.org/0009-0006-5277-507X
Yongkai HuangDepartment of Neurosurgery, Zhuzhou Hospital, Central South University Xiangya School of Medicine, Zhuzhou, China.ORCID https://orcid.org/0009-0003-8188-1355

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Dermatofibrosarcoma protuberans (DFSP) is a rare mesenchymal cell-derived soft tissue tumor, especially on the scalp. As a result, there is a lack of insight into the etiology of its occurrence and the triggers of its recurrence, which makes diagnosis difficult. This paper reports a case with a long follow-up period in an attempt to provide some valuable evidence-based medicine to assist in the clinical work-up of diagnostic. Case Description: We selected a young male who underwent surgical treatment in our hospital in 2013, and his pathological result at that time was "suspected dermatofibrosarcoma protuberans". At the same time, we followed the patient for 6 years and performed a literature review on the current management of DFSP. Six years later, the patient's scalp mass recurred after a head trauma. Based on the patient's medical history and pathogenesis of the disease, we believe that the patient's disease may be related to trauma. Conclusions: DFSP is rare in clinic, and it is easy to be misdiagnosed because of its atypical clinical symptoms and long diagnosis time. This article analyzed the case which has a long-time follow-up and reviewed the literature on DFSP. Therefore, this paper finds that trauma may be a causative factor in the development and recurrence, and provides a basis for evidence-based medicine for the diagnosis and treatment of this disease.

Indexed as

case reportDermatofibrosarcoma protuberans (DFSP)pathogenesisrecurrencetrauma

Identifiers

PMID40330930
PMCPMC12053716

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.